Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,009,832
-$111,724 QoQ
Shares Held
40,531
-0.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Baird Financial Group, Inc. holds $190,822,781 across 25 Biotechnology names. BBIO ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
349,651 | $103,835,857 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,589 | $44,495,563 | |
| 3 | INCY |
Incyte Corp
|
186,860 | $17,587,261 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,771 | $3,916,600 | |
| 5 | TECH |
BIO-TECHNE Corp
|
66,869 | $3,494,573 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
40,531 | $3,009,832 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
41,977 | $2,944,686 | |
| 8 | INSM |
INSMED Inc
|
17,688 | $2,892,341 |
All Filings in BBIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,009,832 | 40,531 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,121,556 | 40,810 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,991,484 | 57,595 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,816,021 | 42,057 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,428,639 | 41,326 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||